Pietro Castellan - Publications

"Diagnostic accuracy and longitudinal outcomes of PI-RADS 3 lesions: A multi-reader comparison between biparametric and multiparametric MRI".

Journal: Current problems in diagnostic radiology

Published: July 07, 2025

PI-RADS in Predicting csPCa: A Comparison Between Academic and Nonacademic Centers.

Journal: The Prostate

Published: August 14, 2024

Management of Urinary Incontinence Following Radical Prostatectomy: Challenges and Solutions.

Journal: Therapeutics and clinical risk management

Published: July 28, 2022

Conspicuity and muscle-invasiveness assessment for bladder cancer using VI-RADS: a multi-reader, contrast-free MRI study to determine optimal b-values for diffusion-weighted imaging.

Journal: Abdominal radiology (New York)

Published: February 02, 2022

Rotterdam mobile phone app including MRI data for the prediction of prostate cancer: A multicenter external validation.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: March 08, 2021

Bladder cancer: do we need contrast injection for MRI assessment of muscle invasion? A prospective multi-reader VI-RADS approach.

Journal: European radiology

Published: August 07, 2020

Conservative management of urinary incontinence following robot-assisted radical prostatectomy.

Journal: Minerva urologica e nefrologica = The Italian journal of urology and nephrology

Published: May 21, 2020

Bioptic intraprostatic chronic inflammation predicts adverse pathology at radical prostatectomy in patients with low-grade prostate cancer.

Journal: Urologic oncology

Published: November 30, 2019

New Antiandrogen Compounds Compared to Docetaxel for Metastatic Hormone Sensitive Prostate Cancer: Results from a Network Meta-Analysis.

Journal: The Journal of urology

Published: November 06, 2019

External validation of Cormio nomogram for predicting all prostate cancers and clinically significant prostate cancers.

Journal: World journal of urology

Published: September 22, 2019

A drug safety evaluation of abiraterone acetate in the treatment of prostate cancer.

Journal: Expert opinion on drug safety

Published: July 30, 2019

Abiraterone acetate for early stage metastatic prostate cancer: patient selection and special considerations.

Journal: Therapeutics and clinical risk management

Published: December 26, 2018